Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly’s tirzepatide ... and for Zepbound’s 15mg weekly dose average ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

At least nine patients using the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and tirzepatide developed ophthalmic complications, of whom seven had nonarteritic anterior ischemic ...

Enter GetSimpli Oral Tirzepatide, a revolutionary product that promises to transform your approach to weight loss and metabolic health. Unlike traditional weight loss methods that often involve ...

CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...

In the 731-patient SUMMIT study, participants were randomly assigned to either tirzepatide at a dose of between 2.5mg and 15mg per week or placebo, on top of their current heart failure treatment.

GPs should not prescribe tirzepatide for weight loss until advised to do so by their local ICB, NHS England has said. This was clarified by the commissioner during a webinar for GPs earlier this month ...

Mounjaro is one brand name for the drug tirzepatide from the pharmaceutical manufacturer Eli Lilly. It’s also FDA-approved to help those with type 2 diabetes manage blood sugar and prescribed ...

Eli Lilly, after tirzepatide's late-stage cardio win, plots regulatory filings this year As for Alzheimer’s and other neurocognitive disorders, the research showed that use of the new diabetes ...